Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study
Background Long-term mental and physical health consequences of COVID-19 (long COVID) are a persistent public health concern. Little is still known about the long-term mental health of non-hospitalised patients with COVID-19 with varying illness severities. Our aim was to assess the prevalence of ad...
Published in: | The Lancet Public Health |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Elsevier
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10037/25514 https://doi.org/10.1016/S2468-2667(22)00042-1 |
id |
ftunivtroemsoe:oai:munin.uit.no:10037/25514 |
---|---|
record_format |
openpolar |
spelling |
ftunivtroemsoe:oai:munin.uit.no:10037/25514 2023-05-15T16:52:45+02:00 Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study Magnúsdóttir, Ingibjörg Lovik, Anikó Unnarsdóttir, Anna Bára McCartney, Daniel L. Ask, Helga Kõiv, Kadri Christoffersen, Lea Arregui Nordahl Johnson, Sverre Urnes Hauksdóttir, Arna Fawns-Ritchie, Chloe Helenius, Dorte Lu, Li Ebrahimi, Omid Vakili Hoffart, Asle Porteous, David J Fang, Fang Jakobsdottir, Johanna Lehto, Kelli Andreassen, Ole Pedersen, Ole Aspelund, Thor Valdimarsdottir, Unnur Anna 2022-03-14 https://hdl.handle.net/10037/25514 https://doi.org/10.1016/S2468-2667(22)00042-1 eng eng Elsevier The Lancet Public Health Nordforsk: 105668 Norges forskningsråd: 324620 info:eu-repo/grantAgreement/ERC/H2020/847776/EU/Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms/CoMorMent/ Magnúsdóttir, Lovik, Unnarsdóttir, McCartney, Ask, Kõiv, Christoffersen, Johnson, Hauksdóttir, Fawns-Ritchie, Helenius, Lu, Ebrahimi, Hoffart, Porteous, Fang, Jakobsdottir, Lehto, Andreassen, Pedersen, Aspelund, Valdimarsdottir. Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study. The Lancet Public Health. 2022;7(5):406-416 FRIDAID 2013102 doi:10.1016/S2468-2667(22)00042-1 2468-2667 https://hdl.handle.net/10037/25514 openAccess Copyright 2022 The Author(s) Journal article Tidsskriftartikkel Peer reviewed publishedVersion 2022 ftunivtroemsoe https://doi.org/10.1016/S2468-2667(22)00042-1 2022-06-22T22:58:56Z Background Long-term mental and physical health consequences of COVID-19 (long COVID) are a persistent public health concern. Little is still known about the long-term mental health of non-hospitalised patients with COVID-19 with varying illness severities. Our aim was to assess the prevalence of adverse mental health symptoms among individuals diagnosed with COVID-19 in the general population by acute infection severity up to 16 months after diagnosis. Methods This observational follow-up study included seven prospectively planned cohorts across six countries (Denmark, Estonia, Iceland, Norway, Sweden, and the UK). Participants were recruited from March 27, 2020, to Aug 13, 2021. Individuals aged 18 years or older were eligible to participate. In a cross-sectional analysis, we contrasted symptom prevalence of depression, anxiety, COVID-19-related distress, and poor sleep quality (screened with validated mental health instruments) among individuals with and without a diagnosis of COVID-19 at entry, 0–16 months from diagnosis. In a cohort analysis, we further used repeated measures to estimate the change in mental health symptoms before and after COVID-19 diagnosis. Findings The analytical cohort consisted of 247 249 individuals, 9979 (4·0%) of whom were diagnosed with COVID-19 during the study period. Mean follow-up was 5·65 months (SD 4·26). Participants diagnosed with COVID-19 presented overall with a higher prevalence of symptoms of depression (prevalence ratio [PR] 1·18 [95% CI 1·03–1·36]) and poorer sleep quality (1·13 [1·03–1·24]) but not symptoms of anxiety (0·97 [0·91–1·03]) or COVID-19-related distress (1·05 [0·93–1·20]) compared with individuals without a COVID-19 diagnosis. Although the prevalence of depression and COVID-19-related distress attenuated with time, individuals diagnosed with COVID-19 but never bedridden due to their illness were consistently at lower risk of depression (PR 0·83 [95% CI 0·75–0·91]) and anxiety (0·77 [0·63–0·94]) than those not diagnosed with COVID-19, whereas patients who ... Article in Journal/Newspaper Iceland University of Tromsø: Munin Open Research Archive Norway The Lancet Public Health 7 5 e406 e416 |
institution |
Open Polar |
collection |
University of Tromsø: Munin Open Research Archive |
op_collection_id |
ftunivtroemsoe |
language |
English |
description |
Background Long-term mental and physical health consequences of COVID-19 (long COVID) are a persistent public health concern. Little is still known about the long-term mental health of non-hospitalised patients with COVID-19 with varying illness severities. Our aim was to assess the prevalence of adverse mental health symptoms among individuals diagnosed with COVID-19 in the general population by acute infection severity up to 16 months after diagnosis. Methods This observational follow-up study included seven prospectively planned cohorts across six countries (Denmark, Estonia, Iceland, Norway, Sweden, and the UK). Participants were recruited from March 27, 2020, to Aug 13, 2021. Individuals aged 18 years or older were eligible to participate. In a cross-sectional analysis, we contrasted symptom prevalence of depression, anxiety, COVID-19-related distress, and poor sleep quality (screened with validated mental health instruments) among individuals with and without a diagnosis of COVID-19 at entry, 0–16 months from diagnosis. In a cohort analysis, we further used repeated measures to estimate the change in mental health symptoms before and after COVID-19 diagnosis. Findings The analytical cohort consisted of 247 249 individuals, 9979 (4·0%) of whom were diagnosed with COVID-19 during the study period. Mean follow-up was 5·65 months (SD 4·26). Participants diagnosed with COVID-19 presented overall with a higher prevalence of symptoms of depression (prevalence ratio [PR] 1·18 [95% CI 1·03–1·36]) and poorer sleep quality (1·13 [1·03–1·24]) but not symptoms of anxiety (0·97 [0·91–1·03]) or COVID-19-related distress (1·05 [0·93–1·20]) compared with individuals without a COVID-19 diagnosis. Although the prevalence of depression and COVID-19-related distress attenuated with time, individuals diagnosed with COVID-19 but never bedridden due to their illness were consistently at lower risk of depression (PR 0·83 [95% CI 0·75–0·91]) and anxiety (0·77 [0·63–0·94]) than those not diagnosed with COVID-19, whereas patients who ... |
format |
Article in Journal/Newspaper |
author |
Magnúsdóttir, Ingibjörg Lovik, Anikó Unnarsdóttir, Anna Bára McCartney, Daniel L. Ask, Helga Kõiv, Kadri Christoffersen, Lea Arregui Nordahl Johnson, Sverre Urnes Hauksdóttir, Arna Fawns-Ritchie, Chloe Helenius, Dorte Lu, Li Ebrahimi, Omid Vakili Hoffart, Asle Porteous, David J Fang, Fang Jakobsdottir, Johanna Lehto, Kelli Andreassen, Ole Pedersen, Ole Aspelund, Thor Valdimarsdottir, Unnur Anna |
spellingShingle |
Magnúsdóttir, Ingibjörg Lovik, Anikó Unnarsdóttir, Anna Bára McCartney, Daniel L. Ask, Helga Kõiv, Kadri Christoffersen, Lea Arregui Nordahl Johnson, Sverre Urnes Hauksdóttir, Arna Fawns-Ritchie, Chloe Helenius, Dorte Lu, Li Ebrahimi, Omid Vakili Hoffart, Asle Porteous, David J Fang, Fang Jakobsdottir, Johanna Lehto, Kelli Andreassen, Ole Pedersen, Ole Aspelund, Thor Valdimarsdottir, Unnur Anna Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study |
author_facet |
Magnúsdóttir, Ingibjörg Lovik, Anikó Unnarsdóttir, Anna Bára McCartney, Daniel L. Ask, Helga Kõiv, Kadri Christoffersen, Lea Arregui Nordahl Johnson, Sverre Urnes Hauksdóttir, Arna Fawns-Ritchie, Chloe Helenius, Dorte Lu, Li Ebrahimi, Omid Vakili Hoffart, Asle Porteous, David J Fang, Fang Jakobsdottir, Johanna Lehto, Kelli Andreassen, Ole Pedersen, Ole Aspelund, Thor Valdimarsdottir, Unnur Anna |
author_sort |
Magnúsdóttir, Ingibjörg |
title |
Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study |
title_short |
Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study |
title_full |
Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study |
title_fullStr |
Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study |
title_full_unstemmed |
Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study |
title_sort |
acute covid-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study |
publisher |
Elsevier |
publishDate |
2022 |
url |
https://hdl.handle.net/10037/25514 https://doi.org/10.1016/S2468-2667(22)00042-1 |
geographic |
Norway |
geographic_facet |
Norway |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
The Lancet Public Health Nordforsk: 105668 Norges forskningsråd: 324620 info:eu-repo/grantAgreement/ERC/H2020/847776/EU/Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms/CoMorMent/ Magnúsdóttir, Lovik, Unnarsdóttir, McCartney, Ask, Kõiv, Christoffersen, Johnson, Hauksdóttir, Fawns-Ritchie, Helenius, Lu, Ebrahimi, Hoffart, Porteous, Fang, Jakobsdottir, Lehto, Andreassen, Pedersen, Aspelund, Valdimarsdottir. Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study. The Lancet Public Health. 2022;7(5):406-416 FRIDAID 2013102 doi:10.1016/S2468-2667(22)00042-1 2468-2667 https://hdl.handle.net/10037/25514 |
op_rights |
openAccess Copyright 2022 The Author(s) |
op_doi |
https://doi.org/10.1016/S2468-2667(22)00042-1 |
container_title |
The Lancet Public Health |
container_volume |
7 |
container_issue |
5 |
container_start_page |
e406 |
op_container_end_page |
e416 |
_version_ |
1766043127838146560 |